-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Edesa Biotech, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2012 to 2023.
- Edesa Biotech, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $264K, a 233% increase year-over-year.
- Edesa Biotech, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $1.45M, a 554% increase year-over-year.
- Edesa Biotech, Inc. annual Nonoperating Income (Expense) for 2023 was $849K, a 3.22% increase from 2022.
- Edesa Biotech, Inc. annual Nonoperating Income (Expense) for 2022 was $823K, a 92% decline from 2021.
- Edesa Biotech, Inc. annual Nonoperating Income (Expense) for 2021 was $10.3M, a 27535% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)